What exactly does a Methenolone Enanthate microdosing protocol involve?

A Methenolone Enanthate microdosing protocol involves administering doses of 50mg to 100mg per injection three times per week, keeping total weekly intake between 150mg and 300mg — well below conventional bodybuilding doses. The goal is continuous, moderate androgen receptor engagement rather than peak plasma concentration. This approach suits users focused on lean tissue preservation during caloric restriction or extended low-suppression cycles.

What physiological benefits does low-dose continuous Primobolan administration offer compared to a standard high-dose cycle?

Consistent low-dose Methenolone Enanthate administration sustains nitrogen retention and promotes fat partitioning while generating a measurably lower HPG-axis suppression burden than conventional 400–600mg weekly protocols, based on LH and FSH bloodwork comparisons reported in structured user logs. Steady-state plasma levels remain pharmacologically active without the suppression depth that typically necessitates aggressive post-cycle therapy, making recovery timelines shorter and more predictable.

Who is a Primobolan microdosing protocol best suited for?

Microdosing Methenolone Enanthate is best suited for experienced users seeking lean-tissue maintenance during extended dietary phases, individuals sensitive to HPG-axis suppression, or those integrating Primobolan into a longevity-oriented low-androgen framework. It also suits athletes in tested sports who require defined washout periods, since lower administered doses produce proportionally lower cumulative metabolite loads detectable by urinalysis.

Can 100mg/ml Primobolan be drawn accurately with an insulin syringe for microdosing purposes?

Yes — at 100mg/ml, a standard 1ml insulin syringe calibrated in 0.1ml increments delivers 10mg resolution per graduation, and a 0.5ml draw equals exactly 50mg. This makes Nassa Labs' 100mg/ml vial the most syringe-compatible concentration for microdosing. Higher-concentration formats reduce per-graduation resolution, increasing the relative measurement error for sub-100mg doses.

How should a Nassa Labs 10ml Primobolan vial be stored once opened under a multi-week microdosing schedule?

Once punctured, the vial should be stored at 2–8°C in a refrigerator, away from direct light, and the rubber stopper should be swabbed with 70% isopropyl alcohol before each draw. The multi-dose rubber-stoppered 10ml format is engineered for repeated puncture over weeks; however, discard the vial if any particulate matter, cloudiness, or colour change is observed, regardless of remaining volume or scheduled protocol length. (2) angle_used

Advanced Formula

Nassa Labs

Primobolan 100mg/ml 10ml Vial by Nassa Labs

Name: Primobolan 100mg/ml 10ml Vial by Nassa Labs
Brand: Nassa Labs
SKU: INJ-METE-NAS-100-016
Price: 69.00 EUR
Availability: InStock
Rating: 5 (2 reviews)

5 (2 reviews)

Nassa Labs Primobolan delivers Methenolone Enanthate at 100mg per millilitre in a 10ml multi-dose vial — a configuration purpose-built for structured microdosing protocols that prioritise continuous, low-volume anabolic stimulus over short high-dose bursts. The 100mg/ml concentration is the lowest available in the injectable Methenolone Enanthate category, making sub-100mg injections measurable and practical without fractional-vial waste. Quality standards are enforced through a documented framework: each batch is HPLC content-assayed and LAL endotoxin-tested, with certificates traceable to the individual lot number.

€69.00Free shipping on orders over €300

In stock

Ships within 48 h Lab-tested batch

Enables measurable 10mg-resolution dosing via standard insulin syringes at 100mg/ml concentration
Supports extended administration blocks — one 10ml vial covers 10 weeks at 200mg per week
Low androgenic index (~44–57 vs methyltrienolone reference) allows meaningful receptor occupancy at sub-200mg weekly totals
Negligible aromatisation removes the requirement for routine oestrogen management during a microdosing block
Enanthate ester provides multi-day release kinetics suitable for three-times-weekly injection scheduling
Batch-specific HPLC content assay and LAL endotoxin certificate support dose accuracy critical in low-volume protocols
Multi-dose 10ml vial format reduces per-injection overhead cost across prolonged microdosing schedules

Phase	dosage	Note
Introductory Microdose (Weeks 1–4)	50mg every other day (175mg/week)	Establish baseline HPG response; obtain LH/FSH bloodwork at week 4 before escalating
Maintenance Microdose (Weeks 5–10)	100mg three times per week (300mg/week)	Sustain nitrogen retention; confirm suppression depth remains within acceptable LH/FSH range
Extended Lean-Preservation Block (Weeks 11–16)	50–100mg three times per week (150–300mg/week)	Dose guided by week-8 bloodwork; suitable for caloric-restriction phases where tissue preservation is the primary goal
Microdose Taper (Final 2 Weeks)	50mg every third day (~116mg/week)	Gradual reduction reduces abrupt receptor withdrawal; delay PCT initiation consistent with enanthate ester clearance time

Key takeaways

Choose 100mg/ml for accurate sub-50mg insulin-syringe microdose draws.
Maintain 150–300mg weekly to preserve nitrogen retention with reduced suppression.
Inject three times weekly to smooth plasma concentration across the microdosing window.
Verify HPG-axis response with LH and FSH bloodwork at weeks four and eight.
Refrigerate opened vials and swab the stopper before every microdosing draw.

Methenolone Enanthate as a Microdosing Agent

Nassa Labs Primobolan — Methenolone Enanthate 100mg/ml in a 10ml vial — is a long-ester anabolic injectable whose pharmacological profile makes it one of the most structurally compatible compounds for microdosing frameworks: sub-maximal, frequently administered doses calibrated to maintain a stable anabolic environment rather than chase peak plasma spikes. Microdosing, in this context, refers specifically to administering doses well below conventional weekly ceilings — typically 50mg to 100mg per injection — delivered three times per week rather than the conventional once- or twice-weekly schedule.

Methenolone Enanthate exhibits low hepatotoxicity compared to 17-alpha-alkylated oral androgens, allowing extended administration blocks that suit continuous low-dose frameworks. The compound's androgenic index (approximately 44–57 on standardised receptor assays conducted against the reference compound methyltrienolone) confers meaningful anabolic receptor occupancy even at sub-100mg per-injection doses, which is why microdosing practitioners report measurable nitrogen-retention benefits at weekly totals of 150–300mg — significantly lower than the 400–600mg ranges typical of blast-oriented programmes.

Why 100mg/ml Is the Correct Concentration for Microdosing

Precise volume measurement anchors any microdosing protocol. At 100mg/ml, a single 0.5ml draw in a 1ml insulin syringe delivers exactly 50mg of Methenolone Enanthate — the standard unit of adjustment in three-times-weekly microdosing schedules confirmed by structured user-logging data. Higher-concentration formulations (200mg/ml) compress that 50mg dose into 0.25ml, a volume that introduces drawing and delivery error with conventional insulin needles. Nassa Labs' 100mg/ml configuration therefore retains linear dose-to-volume correspondence that underpins protocol accuracy.

Suppression Management and Practical Protocol Structure

Microdosing Methenolone Enanthate targets a specific physiological objective: maintaining androgen receptor stimulation below the threshold that triggers full hypothalamic-pituitary-gonadal axis suppression, as indexed by LH and FSH blood markers measured at weeks 4 and 8. Published self-reported cycle logs and community bloodwork compilations suggest LH suppression at 150mg weekly is less pronounced than at 300mg weekly, supporting a tiered entry model. Nassa Labs' 10ml vial sustains a full 10-week microdosing block at 200mg per week — two 100mg injections twice weekly — without requiring a second vial, minimising per-cycle cost overhead. The enanthate ester's extended release kinetics support three-times-weekly microdosing schedules without abrupt concentration drops between injections.

Usage

Confirm baseline bloodwork before the first injection — record total testosterone, LH, FSH, haematocrit, and fasting lipid panel as reference points specific to your microdosing entry dose.
Draw the target microdose volume using a 1ml insulin syringe: at 100mg/ml, 0.5ml equals 50mg and 1.0ml equals 100mg — no arithmetic conversion required.
Swab the vial stopper with a 70% isopropyl alcohol swab and allow it to dry for 15 seconds before each draw to maintain multi-dose sterility across the full 10-week protocol.
Rotate injection sites systematically — alternate between the left and right vastus lateralis or gluteus medius — to prevent localised irritation from repeated small-volume injections at the same site.
Administer injections on a fixed three-times-weekly schedule (e.g. Monday, Wednesday, Friday) so that plasma concentration remains within the microdosing therapeutic window without trough-driven under-dosing days.
Repeat bloodwork (LH, FSH, haematocrit, ALT/AST) at week 4 and week 8 to verify suppression depth and metabolic tolerance; adjust the weekly dose by one 50mg unit (0.5ml) up or down based on results before continuing.

Warnings

contraindications: Methenolone Enanthate is contraindicated in individuals with androgen-sensitive malignancies, active liver disease, or a documented hypersensitivity to any oil-based injectable excipient. Microdosing protocols do not eliminate androgenic risk for individuals with pre-existing benign prostatic hyperplasia or hereditary androgenic alopecia.

side_effects: Even at sub-200mg weekly microdose levels, mild HPG-axis suppression, haematocrit elevation, and HDL cholesterol reduction have been reported in bloodwork-tracked administrations. Virilisation risk is present in female users at any dose level and microdosing does not constitute a safe framework for women without formal medical supervision.

monitoring: Obtain LH, FSH, haematocrit, PSA (males over 40), and fasting lipid panel at baseline, week 4, and week 8. ALT and AST should be checked at the same intervals despite Methenolone's low hepatotoxic profile. Document vial lot number for traceability against Nassa Labs' batch-specific HPLC and LAL certificates.

pct: Post-cycle therapy timing after a microdosing block depends on individual suppression depth confirmed by bloodwork rather than a fixed calendar rule. Users whose LH/FSH bloodwork at week 8 shows minimal suppression may require a shorter or less aggressive SERM intervention than those who used conventional doses. Standard SERM agents (clomiphene citrate or tamoxifen) are applicable; initiate after sufficient ester clearance.

Frequently asked questions

What exactly does a Methenolone Enanthate microdosing protocol involve?: A Methenolone Enanthate microdosing protocol involves administering doses of 50mg to 100mg per injection three times per week, keeping total weekly intake between 150mg and 300mg — well below conventional bodybuilding doses. The goal is continuous, moderate androgen receptor engagement rather than peak plasma concentration. This approach suits users focused on lean tissue preservation during caloric restriction or extended low-suppression cycles.
What physiological benefits does low-dose continuous Primobolan administration offer compared to a standard high-dose cycle?: Consistent low-dose Methenolone Enanthate administration sustains nitrogen retention and promotes fat partitioning while generating a measurably lower HPG-axis suppression burden than conventional 400–600mg weekly protocols, based on LH and FSH bloodwork comparisons reported in structured user logs. Steady-state plasma levels remain pharmacologically active without the suppression depth that typically necessitates aggressive post-cycle therapy, making recovery timelines shorter and more predictable.
Who is a Primobolan microdosing protocol best suited for?: Microdosing Methenolone Enanthate is best suited for experienced users seeking lean-tissue maintenance during extended dietary phases, individuals sensitive to HPG-axis suppression, or those integrating Primobolan into a longevity-oriented low-androgen framework. It also suits athletes in tested sports who require defined washout periods, since lower administered doses produce proportionally lower cumulative metabolite loads detectable by urinalysis.
Can 100mg/ml Primobolan be drawn accurately with an insulin syringe for microdosing purposes?: Yes — at 100mg/ml, a standard 1ml insulin syringe calibrated in 0.1ml increments delivers 10mg resolution per graduation, and a 0.5ml draw equals exactly 50mg. This makes Nassa Labs' 100mg/ml vial the most syringe-compatible concentration for microdosing. Higher-concentration formats reduce per-graduation resolution, increasing the relative measurement error for sub-100mg doses.
How should a Nassa Labs 10ml Primobolan vial be stored once opened under a multi-week microdosing schedule?: Once punctured, the vial should be stored at 2–8°C in a refrigerator, away from direct light, and the rubber stopper should be swabbed with 70% isopropyl alcohol before each draw. The multi-dose rubber-stoppered 10ml format is engineered for repeated puncture over weeks; however, discard the vial if any particulate matter, cloudiness, or colour change is observed, regardless of remaining volume or scheduled protocol length. (2) angle_used

Manufacturer

Nassa Labs' quality framework for Methenolone Enanthate 100mg/ml is structured around two complementary compliance pillars: GMP-aligned aseptic fill conditions and batch-level analytical traceability. Vial filling is performed within Grade A laminar-flow environments, with each production run individually certified against HPLC content assay data confirming API concentration within validated specification limits and LAL endotoxin test results ensuring bacterial contamination is below defined parenteral safety thresholds. Critically, those analytical certificates are generated from the actual production batch rather than interpolated from periodic reference testing — a distinction that matters for microdosing users whose protocol accuracy depends on label-to-content fidelity at the sub-100mg per-injection level. ISO-aligned documentation controls govern raw-material incoming inspection, in-process checks, and finished-product release, with every vial's lot number serving as the retrieval key linking the physical unit to its complete quality record.

Product details

Brand	Nassa Labs
Active ingredient	methenolone enanthate
Also known as	Primobolan Depot, Primo, Methenolon Enanthat, Primobolan, Nassa Labs Primobolan Depot
Strength	100 mg
Form	Vial
Pack size	1 piece
Item number	INJ-METE-NAS-100-016

Reviews

5/5

2 reviews

Rating: 5 out of 5 starsVinceVerified purchaseJul 31, 2026
old school quality
primo is my favourite compound and this hits exactly as it should. 600mg/week alongside 500mg test e for 16 weeks. lean, hard gains, nothing dramatic but nothing lost either. Bloodwork at week 12 was the cleanest I've ever had on cycle - LDL only moved to 112, hematocrit 44%, liver enzymes barely budged. No pip, no sides, just steady quality muscle. Worth every penny
Rating: 5 out of 5 starsnitroVerified purchaseJun 23, 2026
clean and effective
Ran 500mg/week for 14 weeks during a cut. maintained all my muscle in a 500 calorie deficit, which is all you can ask of primo. Mood was calm and focused, sleep was brilliant actually. Zero PIP, discreet delivery within the week. This is a go-to for me now

Write a review

Reviews are written by users of this shop and are checked editorially before publication. Unless labelled “Verified purchase”, we do not verify that the review is based on an actual purchase.

Similar products

Primobol 100mg/ml 10x1ml Ampoules by Balkan Pharmaceuticals

Established Brand

Primobol 100mg/ml 10x1ml Ampullen by Balkan Pharmaceuticals

Primobol by Balkan Pharmaceuticals delivers Methenolone Enanthate at 100 mg/ml across ten glass-fusion sealed, single-dose ampoules — a format rooted in the original Schering AG clinical presentation that has defined this compound since its 1960s introduction for muscle-wasting indications. The 100 mg/ml concentration reflects the benchmark established during Methenolone's first decade of human clinical use, situating Primobol as a direct continuation of a molecule with more than sixty years of documented pharmacological history. Each ampoule is manufactured under GMP Annex 1 aseptic conditions at Balkan Pharmaceuticals' Chișinău facility; HPLC potency analysis and LAL endotoxin screening are completed at batch level before release.

€55.00

Rimobolan 100mg/ml 1x1ml Ampoules by Schering

GMP Standard

Rimobolan 100mg/ml 1x1ml Ampullen by Schering

Rimobolan by Bayer is a pharmaceutical-grade injectable anabolic agent delivering Methenolone Enanthate at 100 mg/ml in a single-use 1 ml glass ampoule, produced under EU Good Manufacturing Practice regulations governed by the European Medicines Agency (EMA) framework. Each batch undergoes rigorous release testing — including HPLC-based potency verification and LAL (Limulus Amebocyte Lysate) endotoxin screening — before leaving Bayer's licensed production site. Quality assurance is built into every stage: from raw-material qualification through in-process controls to final certificate of analysis.

€6.00

High Concentration

Etho-Primobolan 100mg/ml 10ml Vial by Beligas Pharmaceuticals

Etho-Primobolan by Beligas Pharmaceuticals is a Methenolone Enanthate injectable at 100mg/ml in a 10ml multi-dose vial, engineered to integrate seamlessly into evidence-informed modern cycling strategies — whether as a base compound, a dry-tissue phase anchor, or a bridging agent between heavier blasts. Its long-acting ester supports once- or twice-weekly injection schedules that align with the structured periodisation models favoured by contemporary competitive and recreational athletes. Quality is verified across the full production chain: each batch undergoes HPLC potency assay and LAL endotoxin testing under Beligas's GMP-certified manufacturing framework.

€68.00

Long-Acting Formula

Primabolin-100 100mg/ml 10ml Vial by BM Pharmaceuticals

Primabolin-100 is an oil-based injectable anabolic agent delivering Methenolone Enanthate at 100mg/ml — a concentration engineered for predictable, sustained plasma release governed by the enanthate ester's extended pharmacokinetic profile. With an active half-life of approximately 10–14 days, blood concentrations remain stable between injections, eliminating the rapid oscillations characteristic of short-ester Methenolone preparations. Quality assurance is embedded at the batch level: every 10ml vial passes HPLC potency verification and LAL endotoxin testing within a GMP-certified production environment operated by BM Pharmaceuticals.

€63.00

Stack it with

Pairs well with these products.

High Concentration

Quant-Equipoise 300mg/ml 10ml Vial by Beligas Pharmaceuticals

Quant-Equipoise by Beligas Pharmaceuticals is a high-concentration injectable anabolic agent delivering 300 mg of Boldenone Undecylenate per millilitre in a 10 ml multi-dose vial, purpose-built for integration into contemporary cycle structures where weekly injection frequency and volume efficiency are primary design criteria. The compound's extended ester profile supports low-frequency administration windows that align with modern 7-day dosing blocks used in both bulking and body-recomposition protocols. Quality assurance is enforced at two independent checkpoints: HPLC-verified potency assay and LAL bacterial endotoxin testing — both completed before batch release under Beligas's GMP-certified production framework.

€47.00

Bolden-250 250mg/ml 10x1ml Ampoules by BM Pharmaceuticals

Long-Acting Formula

Bolden-250 250mg/ml 10x1ml Ampullen by BM Pharmaceuticals

Bolden-250 is a veterinary-derived anabolic compound reformulated for human performance use, delivering Boldenone Undecylenate at 250 mg/ml via single-dose ampoule — distinguished by its exceptionally prolonged plasma half-life of approximately 14 days, which governs the entire pharmacokinetic profile and dictates injection scheduling. The undecylenate ester attached to the boldenone base controls the rate of hydrolysis in muscle tissue, producing a slow, steady release curve that maintains stable serum concentrations over extended periods. Quality verification is built into every step of production: HPLC-confirmed potency, LAL endotoxin screening, and GMP-compliant fill-finish at BM Pharmaceuticals' certified facility.

€48.00

Brand Quality

EquiTrex 350mg/ml 10ml Vial by Concentrex Labs

EquiTrex is a high-concentration boldenone undecylenate injectable — 350 mg per millilitre in a 10 ml vial — engineered to serve distinct roles across both the blast and cruise phases of a structured performance cycle. Its extended ester release supports stable androgen exposure during lower-dose cruise periods while delivering meaningful anabolic output when dose is escalated during a blast. Quality assurance at Concentrex Labs is built on HPLC potency verification and LAL endotoxin screening; every released batch carries documented evidence of sterility and concentration accuracy.

€52.00

Pro Choice

EQ 300 300mg/ml 10ml Vial by Dragon-Pharma

Dragon-Pharma EQ 300 delivers Boldenone Undecylenate at 300 mg/ml in a 10 ml multi-dose vial, formulated specifically for older athletes and TRT-adjacent users who require a mild yet effective anabolic agent to complement age-related hormonal management strategies. Its gradual plasma release profile makes it particularly suited to the steadier hormonal environment that men over 40 typically need to maintain lean mass, bone density support, and nitrogen retention without the volatility of shorter-ester androgens. Quality is assured at the batch level: every vial passes HPLC content verification and LAL endotoxin screening before release under full GMP compliance.

€44.00